A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Thiothixene

Typical Antipsychotic class · 3 generic manufacturers · 12 ANDAs filed at FDA.

First FDA approval2019-04-05
Generic availableYes · 3 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$3.3M in CY2024 Part D spend33K claims · 6K beneficiaries · 329 plans surveyed

Lowest NADAC
$0.659/unit
8 NDCs benchmarked, lowest of all strengths.
Average NADAC
$1.27
Across all dosage forms in distribution.
Highest NADAC
$2.16
Range is tight.
Plans with PA
176 / 329
Limited PA friction.

Questions a plan sponsor actually asks.

FAQPage schema9 entries indexed · 4 visible
What is Thiothixene used for?

Thiothixene is a Typical Antipsychotic medication tracked in Medicare Part D.

Is there a generic for Thiothixene?

Yes. 12 ANDAs filed at FDA, 3 generic manufacturers currently shipping.

How much does my plan pay for Thiothixene?

Across 329 Part D plans, Thiothixene averages $1.27/unit (NADAC). Lowest available: $0.659/unit. Highest in distribution: $2.16/unit.

Is Thiothixene on the FDA shortage list?

No. Thiothixene is not currently on the FDA Drug Shortage Database.

5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Typical Antipsychotic2 alternatives in D1
01
Haloperidol
Brand: HALOPERIDOL
$0.123Lowest NADAC
21Generic mfrs
$39.4MCY24 Part D spend
Compare →
02
Pimozide
Typical Antipsychotic
$1.25Lowest NADAC
1Generic mfrs
$2.1MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (8 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.